0 0 0 -0.00331034482758614 -0.00331034482758614 -0.00351724137931028 -0.00158620689655165 0.00220689655172409
Sign Up Today X
Thanks for submitting the form.
Stockreport

Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain? [Yahoo! Finance]

Hologic, Inc. (HOLX)  More Company Research Source: Yahoo! Finance
Last hologic, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
Control and Prevention (“CDC”) to develop analyte-specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests aimed at detecting H5N1 bird flu. The ASRs are being developed on the company's Panther Fusion system, a fully automated molecular testing platform that allows labs to quickly consolidate and run multiple assays for women's health, infectious disease and SARS-CoV-2 (COVID-19) testing. The latest development builds on the company's existing strong portfolio of diagnostic solutions, including assays used for the detection of COVID-19. Predicting HOLX Stock Movement Following the News Since the announcement on Dec. 18, HOLX shares edged up 0.3%, finishing at $72.50 yesterday. Hologic's Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay have played a critical role in the global pandemic response, with the company continuing to innovate in this area. In 2023, it received the FDA's clearance for a test that can detect SARS-CoV-2, influenza A [Read more]
IMPACT SNAPSHOT EVENT TIME: HOLX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
HOLX alerts
from News Quantified
HOLX
NEWS
HOLX
Earnings
HOLX
Analyst Actions
HOLX
SEC Filings
Stockreport

Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain? [Yahoo! Finance]

Hologic, Inc.  (HOLX) 
More Company Research Source: Yahoo! Finance
Last hologic, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
Control and Prevention (“CDC”) to develop analyte-specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests aimed at detecting H5N1 bird flu. The ASRs are being developed on the company's Panther Fusion system, a fully automated molecular testing platform that allows labs to quickly consolidate and run multiple assays for women's health, infectious disease and SARS-CoV-2 (COVID-19) testing. The latest development builds on the company's existing strong portfolio of diagnostic solutions, including assays used for the detection of COVID-19. Predicting HOLX Stock Movement Following the News Since the announcement on Dec. 18, HOLX shares edged up 0.3%, finishing at $72.50 yesterday. Hologic's Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay have played a critical role in the global pandemic response, with the company continuing to innovate in this area. In 2023, it received the FDA's clearance for a test that can detect SARS-CoV-2, influenza A [Read more]
IMPACT SNAPSHOT
EVENT TIME:
HOLX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS